CRISPR-Cas systems are found in the genomes of ... strains CFBP2957 and K60T were challenged with a virulent phage, and the CRISPR arrays of bacteriophage-insensitive mutants (BIMs) were analysed.

For example, a 2014 grant of $50,000 went to Barrangou for a research study titled “Novel CRISPR Systems for Efficient Genome ... “We’re proud of the one-of-a-kind high-throughput phage discovery ...

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. After all, it's been less than a year since regulators in the U.S. and E.U. approved its ...

Note that running an executable WAR requires CAS to use an embedded container such as Apache Tomcat, Jetty, etc. The current servlet container is specified as -tomcat. This is slightly faster on ...

CRISPR Therapeutics AG (NASDAQ:CRSP) investors still suffer from the stock's tepid momentum. It has also underperformed its healthcare sector (XLV) and biotechnology peers (XBI). As a result, the ...

Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals. Jennifer Doudna, one of the inventors of the breakthrough gene-editing ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.